Volume 1 Number 2
Editorial
18
The Endeavor Stent System: will it be the next kid in the block? Numero uno, first among equals or equal?EuroInterv.2005;2:123-124
20
Beyond crossing a chronic total occlusion. Are the drug-eluting stents the solution for this old problem?EuroInterv.2005;2:129-131
Working Group 10 column
21
Launching a new journal dedicated to interventional cardiology is a great challenge.EuroInterv.2005;2:133
22
Training in interventional cardiology in Europe: how to move from chaos to rational common programs?EuroInterv.2005;2:135-137
Special article
Clinical research
25
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novocoronary artery lesionsEuroInterv.2005;2:147-156
26
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I TrialEuroInterv.2005;2:157-164
27
One-year clinical outcome of various doses and pharmacokinetic release of paclitaxel eluted from an erodable polymer - Insights from the Paclitaxel In-Stent Controlled Elution Study (PISCES)EuroInterv.2005;2:165-172
28
Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD studyEuroInterv.2005;2:173-180
29
Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgeryEuroInterv.2005;2:181-185
30
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry)EuroInterv.2005;2:186-192
31
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stentEuroInterv.2005;2:193-197
33
150 microgram intracoronary adenosine bolus for accurate fractional flow reserve assessment of angiographically intermediate coronary stenosisEuroInterv.2005;2:204-207
34
Preprocedural creatinine clearance and long term survivalafter successful coronary stentingEuroInterv.2005;2:208-213
35
CMR assessment of AMI patients treated by PCI shows delays in myocardial reperfusion despite initial achievement of TIMI 3 flowEuroInterv.2005;2:214-218
36
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery diseaseEuroInterv.2005;2:219-227
Experimental research
37
The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine modelEuroInterv.2005;2:228-235
38
Inhibition of intimal hyperplasia by the tetracycline derived MMP inhibitor doxycycline in vein graft disease in vitro and in vivoEuroInterv.2005;2:236-243
New devices
39
Assessment of stent dimensions with a novel intracoronary balloon-based system: comparative study versus intravascular ultrasound and quantitative coronary angiography. The CAMUS - Coronary Angioplasty Metricath vs. UltraSound TrialEuroInterv.2005;2:244-251
Volume 1 Number 2 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Boston Scientific
- Conor Medsystems
- Cordis, a Johnson & Johnson company
- Medtronic
- Mentice AB
- Siemens Medical
- Terumo



